Identification of Widespread Antibiotic Exposure in Patients With Cholera Correlates With Clinically Relevant Microbiota Changes
Identification of Widespread Antibiotic Exposure in Patients With Cholera Correlates With Clinically Relevant Microbiota Changes
复制标题
DOI:
10.1093/infdis/jiz299
复制
发表时间:
2019-11-15
影响因子:
6.4
通讯作者:
Nelson, Eric J.
中科院分区:
文献类型:
--
作者:
Alexandrova, Ludmila;Haque, Farhana;Nelson, Eric J.
Background: A first step to combating antimicrobial resistance in enteric pathogens is to establish an objective assessment of antibiotic exposure. Our goal was to develop and evaluate a liquid chromatography-ion trap mass spectrometry (LC/MS) method to determine antibiotic exposure in patients with cholera.Methods: A priority list for targeted LC/MS was generated from medication-vendor surveys in Bangladesh. A study of patients with and those without cholera was conducted to collect and analyze paired urine and stool samples.Results: Among 845 patients, 11% (90) were Vibrio cholerae positive; among these 90 patients, analysis of stool specimens revealed >= 1 antibiotic in 86% and >= 2 antibiotics in 52%. Among 44 patients with cholera and paired urine and stool specimens, >= 1 antibiotic was detected in 98% and >= 2 antibiotics were detected in 84%, despite 55% self-reporting medication use. Compared with LC/MS, a low-cost antimicrobial detection bioassay lacked a sufficient negative predictive value (10%; 95% confidence interval, 6%-16%). Detection of guideline-recommended antibiotics in stool specimens did (for azithromycin; P = .040) and did not (for ciprofloxacin) correlate with V. cholerae suppression. A nonrecommended antibiotic (metronidazole) was associated with decreases in anaerobes (ie, Prevotella organisms; P < .001).Conclusion: These findings suggest that there may be no true negative control group when attempting to account for antibiotic exposure in settings like those in this study.